ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 138,76
-0,70%
Dow Jones
39 863,75
0,14%
DAX
18 724,15
-0,23%
Brent Oil
82,61
-1,10%
Bitcoin
70 057,81
-1,95%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. NewLink Genetics Corporation (NLNK)

  7. NewLink Genetics Corporation (NLNK) Actualités

NLNK

NewLink Genetics (NLNK)

NewLink Genetics Corporation
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:NLNK
DateHeureSourceTitreSymboleSociété
09/06/202023h08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NLNKNewLink Genetics Corporation
02/06/202023h22Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:NLNKNewLink Genetics Corporation
01/06/202012h29Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:NLNKNewLink Genetics Corporation
29/04/202022h15Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:NLNKNewLink Genetics Corporation
07/04/202023h59Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NLNKNewLink Genetics Corporation
07/04/202022h45Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:NLNKNewLink Genetics Corporation
01/04/202012h02Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:NLNKNewLink Genetics Corporation
31/03/202000h33Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:NLNKNewLink Genetics Corporation
30/03/202014h00GlobeNewswire Inc.Lumos Pharma Appoints Joseph S. McCracken, DVM, MS to Board of Directors Rick Hawkins, CEO, appointed Chairman of the BoardNASDAQ:NLNKNewLink Genetics Corporation
18/03/202013h00GlobeNewswire Inc.NewLink Genetics Stockholders Approve Merger with Lumos PharmaNASDAQ:NLNKNewLink Genetics Corporation
06/03/202014h14Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:NLNKNewLink Genetics Corporation
03/03/202022h28Edgar (US Regulatory)Annual Report (10-k)NASDAQ:NLNKNewLink Genetics Corporation
28/02/202015h00GlobeNewswire Inc.NewLink Genetics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate UpdateNASDAQ:NLNKNewLink Genetics Corporation
18/02/202016h07Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:NLNKNewLink Genetics Corporation
14/02/202021h24Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:NLNKNewLink Genetics Corporation
13/02/202022h39Edgar (US Regulatory)Revised Proxy Soliciting Materials (definitive) (defr14a)NASDAQ:NLNKNewLink Genetics Corporation
10/02/202014h32Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (definitive) (defm14a)NASDAQ:NLNKNewLink Genetics Corporation
04/02/202014h04Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)NASDAQ:NLNKNewLink Genetics Corporation
23/12/201922h05GlobeNewswire Inc.NewLink Genetics Announces Exclusive Worldwide License Agreement with Ellipses Pharma for Development of and Rights to Commer...NASDAQ:NLNKNewLink Genetics Corporation
20/12/201916h09GlobeNewswire Inc.NewLink Genetics Announces FDA Approval of Ebola Vaccine V920 (ERVEBO®)NASDAQ:NLNKNewLink Genetics Corporation
16/12/201914h00GlobeNewswire Inc.NewLink Genetics Responds to Proposal from EvercelNASDAQ:NLNKNewLink Genetics Corporation
13/12/201915h12Edgar (US Regulatory)Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a)NASDAQ:NLNKNewLink Genetics Corporation
12/12/201923h31GlobeNewswire Inc.Evercel Announces Rejected Offer to Acquire NewLink GeneticsNASDAQ:NLNKNewLink Genetics Corporation
20/11/201912h39Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (preliminary) (prem14a)NASDAQ:NLNKNewLink Genetics Corporation
12/11/201915h00GlobeNewswire Inc.NewLink Genetics Announces European Commission Grant of Conditional Marketing Approval for Ebola Vaccine V920 (ERVEBO®)NASDAQ:NLNKNewLink Genetics Corporation
06/11/201914h00GlobeNewswire Inc.NewLink Genetics Reports Third Quarter 2019 Financial Results and Provides Corporate UpdateNASDAQ:NLNKNewLink Genetics Corporation
30/10/201913h30GlobeNewswire Inc.NewLink Genetics to Host Its Third Quarter 2019 Conference Call on November 6, 2019NASDAQ:NLNKNewLink Genetics Corporation
21/10/201922h30GlobeNewswire Inc.NewLink Genetics Announces EU Regulatory Committee (CHMP) Recommendation for Conditional Marketing Authorization for Ebola Va...NASDAQ:NLNKNewLink Genetics Corporation
30/09/201922h35GlobeNewswire Inc.NewLink Genetics and Lumos Pharma Enter into Merger Agreement to Form Biopharmaceutical Company Focused on Developing Therapi...NASDAQ:NLNKNewLink Genetics Corporation
17/09/201923h05GlobeNewswire Inc.NewLink Genetics Announces FDA Accepts Partnered Biologics License Application (BLA) and Grants Priority Review for Ebola Vac...NASDAQ:NLNKNewLink Genetics Corporation
 Showing the most relevant articles for your search:NASDAQ:NLNK

Dernières Valeurs Consultées

ASX
MGN
Magellan Petroleum
COIN
SWAPPUSD
Swapp Token
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés